Literature DB >> 11069899

Functional disruption of the CD28 gene transcriptional initiator in senescent T cells.

A N Vallejo1, C M Weyand, J J Goronzy.   

Abstract

We recently reported that aging is accompanied by the emergence of CD4(+)CD28(null) T cells, a functionally aberrant lymphocyte subset rarely seen in individuals younger than 40 years. Here, we directly examined whether the lack of CD28 expression is due to a defect at the level of transcriptional initiation. Molecular studies reveal that CD28 gene transcription is controlled by two sequence motifs, sites alpha and beta. In vitro transcription assays using initiator-dependent DNA templates revealed that reversed polarity or the deletion of either motif inhibited transcription, indicating that alpha/beta sequences constitute a composite initiator. Moreover, nuclear extracts from CD28(null) cells failed to activate transcription of alphabeta-initiator DNA templates. Transcription of such templates was, however, restored with the addition of extracts from CD28(+) cells. Although previously described initiator elements have been defined by a consensus sequence, the alphabeta-initiator has no homology to such sequence. These studies demonstrate that initiators have functions other than positioning elements for the basal transcription complex. Rather, initiators can have a direct role in regulating the expression of specific genes. The gain or loss of initiator activity can be an important determinant of cell phenotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069899     DOI: 10.1074/jbc.M005503200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages.

Authors:  Stefan O Schönland; Consuelo Lopez; Thomas Widmann; Julia Zimmer; Ewa Bryl; Jörg J Goronzy; Cornelia M Weyand
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

2.  Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.

Authors:  Jeffrey N Dock; Rita B Effros
Journal:  Aging Dis       Date:  2011-10       Impact factor: 6.745

3.  Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.

Authors:  A U Engela; C C Baan; N H R Litjens; M Franquesa; M G H Betjes; W Weimar; M J Hoogduijn
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

Review 4.  Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged.

Authors:  Abbe N Vallejo
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Ex vivo apoptosis, CD95 and CD28 expression in T cells of children with juvenile idiopathic arthritis.

Authors:  Sabine Knipp; Oliver Feyen; Jennnifer Ndagijimana; Tim Niehues
Journal:  Rheumatol Int       Date:  2002-12-04       Impact factor: 2.631

Review 6.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 7.  CD28(-) T cells: their role in the age-associated decline of immune function.

Authors:  Nan-Ping Weng; Arne N Akbar; Jorg Goronzy
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

8.  Molecular mechanisms involved in the aging of the T-cell immune response.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Carlos López-Larrea
Journal:  Curr Genomics       Date:  2012-12       Impact factor: 2.236

9.  The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis.

Authors:  Andrzej Pawlik; Lidia Ostanek; Iwona Brzosko; Marek Brzosko; Marek Masiuk; Boguslaw Machalinski; Barbara Gawronska-Szklarz
Journal:  Arthritis Res Ther       Date:  2003-05-14       Impact factor: 5.156

Review 10.  Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Res Ther       Date:  2003-08-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.